Psoriasis

Dermatologists should consider prescribing topical halcinonide 0.1% ointment as an adjunctive therapy for patients with moderate to severe plaque psoriasis that inadequately respond to biologics, according to a study.

Salicylic acid and ceramides-containing skincare products may soften psoriatic plaques, allowing for improved absorption of topical treatments, suggesting skin care may play a role in managing psoriasis, according to a study.

Since topical steroids remain the cornerstone of psoriasis treatment, a group of dermatologists specializing in psoriasis gathered to discuss the most current management guidelines for topical psoriasis treatment.

After 28 weeks of treatment, tildrakizumab significantly improved clinical status and reduced disease activity while also maintaining a consistent safety profile among patients with moderate to severe plaque psoriasis, according to a study.

Risankizumab demonstrated a consistent long-term safety profile and clinical response in patients with moderate to severe plaque psoriasis, according to a phase 3 study.

Zerigo Health has appointed Lisa Rometty as its new CEO, according to a company release.

Factors associated with multiple biologic failure in patients with psoriasis may indicate who would benefit from frequent follow-up, according to a study.

In this Healio video exclusive, Melodie Young, MSN, RN, ANP-C, discusses highlights in psoriasis from Maui Derm NP+PA.

Pediatric patients with palmoplantar plaque psoriasis were more likely to use combination treatment due to the inefficacy of biologics as a primary treatment in this indication, according to a study.

As August marks the beginning of Psoriasis Action Month, Healio Dermatology has compiled a list of the top psoriasis stories from the past year that bring awareness to the plight of patients with psoriasis and the work of clinicians.